CoRISMA MCS System
Hemodynamic monitoring for guiding volume/inotrope management in cardiogenic shock (critical care & perioperative)
Key Facts
About CoRISMA MCS Systems
CoRISMA MCS Systems, founded in 2010 and headquartered in San Diego, is a private medical device company advancing a novel non-invasive monitoring platform for cardiovascular care. The company's flagship CoRISMA MCS system uses multi-channel signal processing to provide continuous, real-time data on cardiac output and other hemodynamic parameters, targeting the significant unmet need in managing conditions like cardiogenic shock. While likely pre-revenue or in early revenue stages, CoRISMA is positioning its technology as a potential alternative to more invasive pulmonary artery catheters, aiming to improve patient outcomes and reduce healthcare costs in critical care and surgery. The company appears to be in a commercial or late-stage development phase for its core system, seeking adoption in hospital settings.
View full company profile